NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Sunday, March 14, 2010 6:49 PM

Aurobindo Pharma Ltd

Type: Company

Name: Aurobindo Pharma Ltd (Aurobindo Pharma Limited)

Nationality: India

Fact Sheet: Fact Sheet for Aurobindo Pharma Limited

First Reported Mar 12 2010 - Updated Mar 12 2010 - 1 Documents

AstraZeneca PLC

Torrent Pharmaceuticals signs license agreement with AstraZeneca

Torrent Pharmaceuticals has singed a supply and licensing agreement with the UK based drug maker AstraZeneca. AstraZeneca, a $32.8-billion enterprise, is the second biggest drug maker in the UK and seventh-largest pharmaceutical company in the world. ... [Published Mar 12 2010 by Stockwatch.in]

Entities: Torrent Pharmaceuticals Ltd., AstraZeneca PLC, Torrent Group, Aurobindo Pharma Ltd, Bovine Spongiform Encephalopathy

First Reported Mar 10 2010 - Updated Mar 10 2010 - 1 Documents

Local pharma can and should step up outsourcing play

In the late nineties, when big pharmaceutical companies starting feeling the burden of over-sized research units in the face of a dwindling pipeline of molecules, they started looking at ways to source manufacturing at lower costs and to farm out semi-skilled ... [Published Mar 10 2010 by DNA India]

Entities: Cadila Healthcare Limited, Shasun Chemicals & Drugs Ltd, Altana AG

First Reported Mar 10 2010 - Updated Mar 10 2010 - 1 Documents

Cipla Ltd

Technical picks: TCS, Aurobindo Pharma, Cipla

Following stocks have been recommended for intra-day trading on Mar. 10, 2010:ICICI Securities:TCSBuy above Rs 770 with stop loss of Rs 765 for a target of Rs 780/ 785/ Higher.Aurobindo PharmaBuy above Rs 974 with stop loss of Rs 967 for a target of Rs ... [Published Mar 10 2010 by MyIris]

Entities: Aurobindo Pharma Ltd, Cipla Ltd, ICICI

First Reported Mar 10 2010 - Updated Mar 10 2010 - 1 Documents

Live stock calls: BUY Aurobindo Pharma

Edelweiss makes a buy call on Aurobindo Pharma at a target price of Rs 1250 ... [Published Mar 10 2010 by UTVi]

Entities: Aurobindo Pharma Ltd

First Reported Mar 09 2010 - Updated Mar 09 2010 - 1 Documents

Food and Drug Administration

Aurobindo Pharma gets final approval for Cetirizine

Aurobindo Pharma has received the final approval for cetirizine hydrochloride solution 1mg/mL (OTC) from the US Food and Drug Administration (US FDA). This approval of cetirizine hydrochloride solution is under over-the-counter (OTC) product category ... [Published Mar 09 2010 by Express Pharma]

Entities: Aurobindo Pharma Ltd, Urticaria, Food and Drug Administration

First Reported Mar 04 2010 - Updated Mar 05 2010 - 2 Documents

Aurobindo launches new division for CRAMS

Aurobindo Pharma Ltd, a Rs 3,000 crore Hyderabad based pharma giant, has established AuroSource, a service oriented and customer-centric division with in the company. The new division will provide custom R&D and manufacturing (CRAMS) services for large, ... [Published Mar 05 2010 by PharmaBiz]

Entities: Life Cycle, Aurobindo Pharma Ltd, Health Care, Hyderabad

First Reported Mar 04 2010 - Updated Mar 05 2010 - 2 Documents

Pfizer Inc

Aurobindo in talks on out-licensing

Tags: Aurobindo, out-licensing, Talks, Stock Market Hyderabad-based Aurobindo Pharma is working on two out-licensing deals, which are expected to befinalised within the next three months.The company already has similar agreements with some pharmaceutical ... [Published Mar 05 2010 by Financial Chronicle]

Entities: Pfizer Inc, Aurobindo Pharma Ltd, Manufacturing Process

First Reported Mar 04 2010 - Updated Mar 05 2010 - 1 Documents

Pharmaceuticals Market in Australia forecast to increase at a compound annual growth rate (CAGR) of 3.16%

Australia Pharmaceuticals and Healthcare Report Q2 2010Refer to a friend2010-03-04 13:49:01 - Australia Pharmaceuticals and Healthcare Report Q2 2010 - a new market research report on companiesandmarkets.comAccording to our updated Pharmaceuticals Business ... [Published Mar 04 2010 by PR inside]

Entities: CAGR, Australia, Aurobindo Pharma Ltd, Australian Competition and Consumer Commission

First Reported Mar 03 2010 - Updated Mar 04 2010 - 4 Documents

Aurobindo gets nod for antibiotic drug

Aurobindo Pharma Ltd today said it has received approval for antibiotic drug Cefuroxime Axetil tablets of 250 mg and 500 mg strengths from Health Canada.Cefuroxime Axetil, used to treat patients with mild to moderate infections, is the genric equivalent ... [Published Mar 04 2010 by Central Chronicle]

Entities: Health Canada, Ceftin, Aurobindo Pharma Ltd

First Reported Mar 03 2010 - Updated Mar 03 2010 - 2 Documents

`Buy` Aurobindo Pharma, target Rs 1,283: Karvy

Karvy has recommended a `Buy` on Aurobindo Pharma with a price target of Rs 1,283 as against the market price (CMP) of Rs 920 in its report dated Mar. 3, 2010.``The ramp-up in the regulated formulations space on the back of supply tie-ups across geographies ... [Published Mar 03 2010 by MyIris]

Entities: Aurobindo Pharma Ltd, Product Mix, CAGR

First Reported Feb 25 2010 - Updated Feb 25 2010 - 4 Documents

Aurobindo Gets FDA Nod for HIV Drug

Hyderabad-based pharmaceutical company Aurobindo Pharma announced Thursday that it has received the tentative approval to manufacture and market Nevirapinetablets for oral suspension 50mg from the US Food and Drug Administration. ... [Published Feb 25 2010 by FDA News]

Entities: Food and Drug Administration, HIV/AIDS, Nevirapine, Aurobindo Pharma Ltd

First Reported Feb 25 2010 - Updated Feb 25 2010 - 2 Documents

Aurobindo Pharma gets U.S. nod for nevirapine tabs

MUMBAI (Reuters) - Aurobindo Pharma Ltd (AUROPHARM.NS : 922.5 -7.2) said on Thursday it has received tentative US FDA approval for HIV treatment drug, nevirapine, in tablet form.(Reporting by Kaustubh Kulkarni; Editing by Harish Nambiar)(For more news ... [Published Feb 25 2010 by Yahoo! India]

Entities: Aurobindo Pharma Ltd, Boney Kapoor, Yahoo! Inc, Harish Nambiar

Quotes

...The aim is to tap large, midsized and emerging biotech and pharma companies, Aurobindo said. "We have found out that companies are looking for something more than just outlicensing. AuroSource would help them in streamlining their manufacturing process and focus on their areas of expertise" Reddy said. It would also help companies cut costs, he added

Aurobindo in talks on out-licensing [Financial Chronicle - Mar 05 2010]

"High leverage and possible inability to refinance FCCBs were two of the key overhangs on the stock but now the FCCB conversion appears possible and the debt/equity would substantially ease going forward. For the 9 months ended December 2009 the company has reported an EPS of Rs. 79.81. The company’s PAT is expected to grow at a CAGR of 50% over FY09-12 on account of its strategic tie-up with Pfizer and other MNC companies to distribute its products across US, Europe, Asia, Latin America and West Asia which will significantly improve its reach. We recommend a buy on the stock for a target price of Rs 1800 in 18 months discounting FY12E earnings at 15x."

Buy Aurobindo Pharma; target of Rs 1800: SKP Research [Moneycontrol.com - Mar 05 2010]

More Content

sort by: Date \| Relevance
Torrent Pharmaceuticals signs license agreement... [Stockwatch.in - Mar 12 2010]
Navigating the Global Pharmaceutical Supply Chain [Pharmaceutical Technology - Mar 12 2010]
Sensex continues to trade flat; Hindalco, M&... [MyIris - Mar 12 2010]
Sensex opens flat with positive bias; Sterlite,... [MyIris - Mar 12 2010]
AstraZeneca in supply deal with torrent pharma [Business Standard India - Mar 11 2010]
Torrent inks licensing & supply agreement ... [Economictimes - Mar 11 2010]
Birla Sun Life picks pharma, media, chemical; s... [Moneycontrol.com - Mar 11 2010]
Sensex opens flat with negative bias; Wipro, Gr... [MyIris - Mar 11 2010]
Local pharma can and should step up outsourcing... [DNA India - Mar 10 2010]
Technical picks: TCS, Aurobindo Pharma, Cipla [MyIris - Mar 10 2010]
Live stock calls: BUY Aurobindo Pharma [UTVi - Mar 10 2010]
Aurobindo Pharma gets final approval for Cetiri... [Express Pharma - Mar 09 2010]
The FCCB issue [Hindu Business Line - Mar 06 2010]
Indian Market Ends Volatile Session Flat [Daily Markets - Mar 05 2010]
Aurobindo launches new division for CRAMS [PharmaBiz - Mar 05 2010]
Aurobindo Pharma Opens AuroSource To Offer CRAMS [Pharmaceutical Business Review - Mar 05 2010]
Aurobindo Pharma sets up new division [The Hindu - Mar 05 2010]
Aurobindo in talks on out-licensing [Financial Chronicle - Mar 05 2010]
Buy Aurobindo Pharma; target of Rs 1800: SKP Re... [Moneycontrol.com - Mar 05 2010]
AstraZeneca sues Sun Pharma in us court [Business Standard India - Mar 04 2010]
LIFE SCIENCES: AstraZeneca upbeat on Crestor [Business & Finance - Mar 04 2010]
Aurobindo may tie-up with 2 pharma firms [Deccan Chronicle - Mar 04 2010]
AstraZeneca upbeat on Crestor patent as trial ends [Yahoo! Malaysia - Mar 04 2010]
Aurobindo Pharma sets up AuroSource [Hindu Business Line - Mar 04 2010]
Aurobindo Pharma introduces AuroSource [MyIris - Mar 04 2010]
Pharmaceuticals Market in Australia forecast to... [PR inside - Mar 04 2010]
Takeda files Para IV infringement suit against ... [PharmaBiz - Mar 04 2010]
Aurobindo opens new CRAMS facility [Bio Spectrum Asia - Mar 04 2010]
Investors can accumulate Strides Arcolab at thi... [Economictimes - Mar 04 2010]
Sensex trades sluggish; down 59.70 pts [MyIris - Mar 04 2010]

Blogs

sort by: Date \| Relevance
Gilead Set to Benefit From Newest HIV Drug [Biotech Sector and Stocks Analysis from Seeking ... - Feb 18 2010] EP Vantage submits:Gilead Sciences (GILD) has gone some way to ensuring that its dominance of the HIV market continues after phase II data from its "Quad" pill presented ...
Symphony Entity Sells Shares In Strides Arcolabs [VCCircle Feeds - Jan 14 2010] Zenith Pharmaceuticals, the single largest shareholder in Bangalore-based drug-maker Strides Arcolab Ltd, is offloading stake in the company. Zenith belongs to ...
Pfizer Expands Generics Portfolio with Indian P... [Healthcare Sector and Stocks Analysis from Seek ... - Jan 12 2010] The Burrill Report submits: Pfizer (PFE) is expanding its burgeoning generics business through a new partnership with India's Strides Arcolab, with which it will ...